Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Co. stock logo
ATPC
Agape ATP
$2.06
-4.1%
$1.63
$0.90
$8.00
$103.06M-0.551.75 million shs83,146 shs
Celcuity Inc. stock logo
CELC
Celcuity
$10.88
+2.1%
$10.16
$7.58
$19.77
$414.34M0.56297,306 shs17,519 shs
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$4.37
-6.9%
$6.45
$4.24
$28.41
$394.31M2.151.77 million shs538,265 shs
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
$3.81
+7.3%
$3.50
$2.62
$12.50
$394.76M0.8254,163 shs53,644 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Co. stock logo
ATPC
Agape ATP
+5.91%+6.44%+14.97%+132.18%-57.00%
Celcuity Inc. stock logo
CELC
Celcuity
-0.37%-1.57%+4.00%-19.07%-36.61%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
+5.39%-6.20%-11.34%-69.53%-82.57%
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
+4.11%+1.43%-11.69%-24.31%+354,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Co. stock logo
ATPC
Agape ATP
0.4332 of 5 stars
0.05.00.00.01.40.00.0
Celcuity Inc. stock logo
CELC
Celcuity
2.1662 of 5 stars
3.61.00.00.03.32.50.0
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
3.4341 of 5 stars
3.92.00.00.02.70.82.5
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Co. stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Celcuity Inc. stock logo
CELC
Celcuity
3.17
Buy$30.80183.22% Upside
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
1.86
Reduce$15.00243.64% Upside
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ATPC, FTRE, CELC, and SBC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Celcuity Inc. stock logo
CELC
Celcuity
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$27.00 ➝ $27.00
5/15/2025
Celcuity Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
5/14/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/14/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.00
5/14/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$7.00 ➝ $5.00
5/13/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$6.00 ➝ $5.00
5/2/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$7.00
4/11/2025
Celcuity Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
4/10/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Underweight$12.00 ➝ $6.00
4/9/2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $10.00
4/1/2025
Celcuity Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$29.00 ➝ $29.00
(Data available from 5/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Co. stock logo
ATPC
Agape ATP
$1.29M79.70N/AN/A$1.14 per share1.81
Celcuity Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/A$5.48 per shareN/A
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$2.69B0.15$0.70 per share6.28$19.58 per share0.22
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
$205.42M1.92$0.08 per share49.20($1.68) per share-2.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Co. stock logo
ATPC
Agape ATP
-$2.10M-$0.60N/AN/A-194.09%-74.71%-56.08%N/A
Celcuity Inc. stock logo
CELC
Celcuity
-$63.78M-$3.03N/AN/AN/AN/A-62.66%-39.78%N/A
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
-$3.40M-$8.79N/A3.411.78-10.99%2.00%0.80%N/A
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
$340KN/A0.000.68N/AN/A-11.59%-7.05%6/17/2025 (Estimated)

Latest ATPC, FTRE, CELC, and SBC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/15/2025Q1 2025
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
$0.11$0.21+$0.10$0.21$51.52 million$47.33 million
5/14/2025Q1 2025
Celcuity Inc. stock logo
CELC
Celcuity
-$0.95-$0.86+$0.09-$0.86N/AN/A
5/12/2025Q1 2025
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
-$0.07$0.02+$0.09-$6.25$609.63 million$651.30 million
3/31/2025Q4 2024
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.20N/A-$0.20N/A$0.36 million
3/31/2025Q4 2024
Celcuity Inc. stock logo
CELC
Celcuity
-$0.72-$0.85-$0.13-$0.85N/AN/A
3/28/2025Q4 2024
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
$0.17$0.18+$0.01$0.06$56.34 million$57.90 million
3/3/2025Q4 2024
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$0.36$0.18-$0.18-$0.68$703.22 million$697.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Co. stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Celcuity Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/AN/A
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
N/AN/AN/AN/AN/A
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Co. stock logo
ATPC
Agape ATP
0.05
3.59
3.53
Celcuity Inc. stock logo
CELC
Celcuity
0.65
10.35
10.36
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
0.74
1.18
1.18
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
0.06
2.79
2.76

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
0.01%
Celcuity Inc. stock logo
CELC
Celcuity
63.33%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
N/A
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
60.82%

Insider Ownership

CompanyInsider Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
9.67%
Celcuity Inc. stock logo
CELC
Celcuity
15.77%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
0.12%
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
63.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Co. stock logo
ATPC
Agape ATP
4050.01 million3.60 millionNot Optionable
Celcuity Inc. stock logo
CELC
Celcuity
4037.84 million31.27 millionOptionable
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
18,00090.50 million89.59 millionOptionable
SBC Medical Group Holdings Incorporated stock logo
SBC
SBC Medical Group
N/A103.61 million37.19 millionN/A

Recent News About These Companies

SBC Medical Group Holdings, Inc. Purchases 5 BTC
SBC SBC Medical Group Holdings Incorporated

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$2.06 -0.09 (-4.14%)
As of 11:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Celcuity stock logo

Celcuity NASDAQ:CELC

$10.88 +0.23 (+2.11%)
As of 11:32 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Fortrea stock logo

Fortrea NASDAQ:FTRE

$4.36 -0.33 (-6.93%)
As of 11:32 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

SBC Medical Group stock logo

SBC Medical Group NASDAQ:SBC

$3.81 +0.26 (+7.32%)
As of 11:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.